Criteria to Reevaluate Anti-drug Antibody Assay Cut Point Suitability in the Target Population

Authors:

Abstract
After tier 1 and 2 cut points for anti-drug antibody (ADA) assays are derived during pre-study assay validation in a population, there is a need to verify the continued appropriateness of the...